HistoIndex Partners with Houston Research Institute to Expand Advanced MASH Diagnostic Services SINGAPORE, Jan. 21, 2026 /PRNewswire/ — HistoIndex, a pioneer in AI-driven digital pathology solutions for chronic liver disease, has announced a strategic partnership with Houston Research Institute (HRI). HRI is a leading research institute focused on conducting clinical trials in hepatology and gastroenterology, with a […]

HistoIndex to Debut FibroSIGHT™ Plus and Showcase Latest Scientific Findings at AASLD The Liver Meeting® 2025 SINGAPORE, Oct. 15, 2025 /PRNewswire/ — HistoIndex, a pioneering leader in digital pathology solutions for chronic liver disease, is returning to The Liver Meeting® (TLM) 2025, hosted by the American Association for the Study of Liver Diseases (AASLD). The conference, which

HistoIndex Marks Another Step Forward with FibroSIGHT™ Plus: Introducing AI-based Quantitative Analysis in Fibrosis Assessment SINGAPORE, Aug. 10, 2025 /PRNewswire/ — HistoIndex, a pioneering leader in digital pathology solutions for chronic liver disease, has announced the launch of FibroSIGHT™ Plus, its second Laboratory Developed Test (LDT) available in the United States. Building on the foundation of FibroSIGHT™[1], which debuted

HistoIndex Secures SGD 9 Million Investment to Drive Next Phase of Expansion SINGAPORE, May 2, 2025 /PRNewswire/ — HistoIndex, known for its groundbreaking biophotonic Second Harmonic Generation (SHG) technology and a pioneering leader in Artificial Intelligence (AI) digital pathology for the management of fibrotic diseases, has announced the close of a S$9 million investment round to support its next

A New Standard in Clinical Care for MASH Patients: HistoIndex Launches FibroSIGHT™ SINGAPORE, March 17, 2025 /PRNewswire/ — HistoIndex, a global leader in stain-free digital pathology solutions for managing fibrotic diseases, has announced the launch of their first Laboratory Developed Test (LDT) FibroSIGHT™ – now available in the United States. This marks a significant milestone

BRIDGING CLINICAL RESEARCH AND CLINICAL CARE WITH AI-AIDING PATHOLOGISTS TOOL SINGAPORE, Dec. 9, 2024 /PRNewswire/ — A newly published collaborative study[1] in the Journal of Hepatology, featuring HistoIndex – a global leader in stain-free digital pathology solutions for managing fibrotic diseases – alongside Merck & Co., MSD, Virginia Commonwealth University (VCU), The National Institutes of Health (NIH) and a panel of distinguished international